订货电话
400-1683301
800-8283301
电话订货时间:
周一到周五9:00-17:00
订货邮件
order@beyotime.com
订货QQ
4001683301
微信在线咨询
订单下载
碧云天订单.xls

试剂>

核酸相关>

菌种与质粒>

报告基因质粒

pNFκB-TA-luc (报告基因质粒)
产品编号: D2207-100μg
产品包装: 100μg
产品价格: 1086.00元
产品简介
使用说明
产品图片
相关产品
相关论文
产品问答
产品编号 产品名称 产品包装 产品价格
D2207-100μg pNFκB-TA-luc (报告基因质粒) 100μg 1086.00元

      pNFκB-TA-luc (报告基因质粒)是碧云天自行研发的用于检测NFκB转录活性水平的报告基因质粒。pNFκB-TA-luc是以碧云天的pGL6-TA质粒为模板,在其多克隆位点插入了多个NFκB结合位点,可以高灵敏度地检测NFκB的激活水平。
      pGL6-TA质粒是用于在哺乳动物细胞中进行萤火虫萤光素酶(firefly luciferase)报告基因检测的新一代质粒。该报告基因质粒比Promega公司的pGL3系列有了全面的改进,一方面对于luciferase的编码进行了改进,确保能更好地在哺乳动物细胞中进行表达,同时对整个质粒中所有的可以被预测出的可能的转录因子结合位点全部进行了适当的突变处理,在保持原有功能不变的情况下,使各种转录因子在质粒上的非特异性结合降到最低。
      萤光素、萤光素酶、萤火虫萤光素酶和海肾萤光素酶也经常被称作荧光素、荧光素酶、萤火虫荧光素酶和海肾荧光素酶。
      pNFκB-TA-luc质粒的主要信息如下:

Base pairs 5651
NFκB response element (κB) 26-65
Minimal TA promoter (pTA) 88-110
luc2 reporter gene 152-1804
SV40 late poly(A) signal 1839-2060
SV40 early enhancer/promoter 2108-2526
Synthetic neomycin phosphotransferase
(Neor) coding region 2551-3345
Synthetic poly(A) signal 3370-3418
Reporter Vector primer 4 (RVprimer4) binding region 3485-3504
ColE1-derived plasmid replication origin 3742
Synthetic Beta-lactamase (Ampr) coding region 4533-5393
Synthetic poly(A) signal/transcriptional pause site 5498-5651
Reporter Vector primer 3 (RVprimer3) binding region 5600-5619

      pNFκB-TA-luc质粒的图谱如下:

      pNFκB-TA-luc的多克隆位点及NFκB response element的详细图谱如下:

BglI KpnI NheI NFkB response elememt
1 GGCCTAACTG GCCGGTACCG
CTAGC GGGAA
TTTCCGGGAA
TTTCCGGGAA
CCGGATTGAC CGGCCATGGC
GATCG CCCTT
AAAGGCCCTT
AAAGGCCCTT
BglII HindIII Minimal TA promoter
51 TTTCCGGGAA
TTTCC AGATC
TGCAGAAGCT
TAGACAC TAG
AGGGTATATA
AAAGGCCCTT
AAAGG TCTAG
ACGTCTTCGA
ATCTGTG ATC
TCCCATATAT

      pNFκB-TA-luc中没有的酶切位点(Restriction enzymes that do not cut pNFκB-TA-luc)包括:

Aat II Afl II Asc I Ase I Bsa I BsaA I BsiW I BspM II
BssH II Eco72 I EcoR I EcoR V Mlu I Nde I Nru I PaeR7 I
PflM I Pme I Pml I Psp1406 I PspA I Rsr II Sac I Sma I
SnaB I Spl I Srf I Tth111 I Vsp I Xcm I Xho I Xma I

      pNFκB-TA-luc中的单酶切位点(Restriction enzymes that cut pNFκB-TA-luc once)包括:

Sfi I GGCCN,NNN`NGGCC 9 BstB I TT`CG,AA 3421
Bgl I GCCN,NNN`NGGC 9 Sal I G`TCGA,C 3435
Acc65 I G`GTAC,C 15 Afl III A`CRYG,T 3685
Asp718 G`GTAC,C 15 ApaL I G`TGCA,C 3999
Kpn I G,GTAC`C 19 HgiE II ACCNNNNNNGGT -1/13 4264
Nhe I G`CTAG,C 21 Not I GC`GGCC,GC 4505
Bgl II A`GATC,T 67 BstX I CCAN,NNNN`NTGG 4529
Hind III A`AGCT,T 77 BstE II G`GTNAC,C 4532
BsrG I T`GTAC,A 643 Ahd I GACNN,N`NNGTC 4607
Dra III CAC,NNN`GTG 1299 Bsu36 I CC`TNA,GG 4963
Gsu I CTGGAG 21/19 1532 Pvu I CG,AT`CG 4977
Bpm I CTGGAG 22/20 1533 Sac II CC,GC`GG 5001
Mun I C`AATT,G 1979 Bst1107 I GTA|TAC 5117
BamH I G`GATC,C 2072 Xca I GTA|TAC 5117
Stu I AGG|CCT 2505 Spe I A`CTAG,T 5436
EcoN I CCTNN`N,NNAGG 3026 BsmA I GTCTC`/9 5448
BsiC I TT`CG,AA 3421 BsmB I CGTCTC 7/11 5449

      pNFκB-TA-luc质粒中推荐使用的测序引物序列如下:
      RVprimer3(5600-5619):
      CTA GCA AAA TAG GCT GTC CC
      pNFκB-TA-luc的全序列信息:D2207-pNFkappaB-TA-luc-seq.txt
包装清单:

产品编号 产品名称 包装
D2207-1μg pNFκB-TA-luc (报告基因质粒) 1μg
D2207-100μg pNFκB-TA-luc (报告基因质粒) 100μg
说明书 1份

保存条件:
      -20℃保存。
注意事项:
      本质粒未经碧云天书面许可不得用于任何商业用途,也不得移交给订货人所在实验室外的任何个人或单位。
      本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
      为了您的安全和健康,请穿实验服并戴一次性手套操作。

使用说明:
1. 首次使用1μg包装的本产品时,请先取少量本质粒转化大肠杆菌,进行质粒小量、中量或大量抽提后再用于后续用途。抽提获得的质粒可以通过酶切电泳进行鉴定,或通过测序进行鉴定。
2. 100μg包装的本产品质粒浓度为0.1μg/μl, 共1ml。可以直接用于酶切或者转染细胞。
3. pNFκB-TA-luc可用常规的细胞转染方法转染细胞。检测时可以采用碧云天的萤火虫萤光素酶报告基因检测试剂盒(RG005/RG006)或双萤光素酶报告基因检测试剂盒(RG027/RG028)。
4. TNF-α、IL-1β和LPS等是常见的可以激活NFκB的试剂,可以用作pNFκB-TA-luc报告基因检测时的阳性对照。

相关产品请点击如下按钮:

使用本产品的文献:
1. Yuan D, Pan Y, Zhang J, Shao C.
Role of nuclear factor-kappaB and P53 in radioadaptive response in Chang live cells.
Mutat Res. 2010 Jun 1;688(1-2):66-71.
2. Chen L, Xu YY, Zhou JM, Wu YY, E Q, Zhu YY.
TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells.
Oncol Rep. 2012 Jul;28(1):200-6.
3. Guo Z, Chen L, Zhu Y, Zhang Y, He S, Qin J, Tang X, Zhou J, Wei Y.
Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of humanhepatocellular carcinoma cells.
Oncol Rep. 2012 Feb;27(2):396-402.
4. Cheng J, Sun Y, Zhang X, Zhang F, Zhang S, Yu S, Qiu X, Tan L, Song C, Gao S, Wu Y, Ding C.
Toll-like receptor 3 inhibits Newcastle disease virus replication through activation of pro-inflammatory cytokines and the type-1 interferon pathway.
Arch Virol. 2014 Nov;159(11):2937-48.
5.Xue H, Gan F, Zhang Z, Hu J, Chen X, Huang K.
Astragalus polysaccharides inhibits PCV2 replication by inhibiting oxidative stress and blocking NF-κB pathway.
Int J Biol Macromol. 2015 Nov;81:22-30.
6.Hong Y, Zhou L, Xie H, Wang W, Zheng S.
Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression.
Biochem Biophys Res Commun. 2015 Jun 5;461(3):513-8.
7.Cheng KY, Guo F, Lu JQ, Cao YZ, Wang TC, Yang Q, Xia Q.
MnTM-4-PyP modulates endogenous antioxidant responses and protects primary cortical neurons against oxidative stress.
CNS Neurosci Ther. 2015 May;21(5):435-45.
8.Li DD, Pang HG, Song JN, Huang H, Zhang M, Zhao YL, Sun P, Zhang BF, Ma XD.
The rapid lipopolysaccharide-induced release of matrix metalloproteinases 9 is suppressed by simvastatin.
Cell Biol Int. 2015 Jul;39(7):788-98.
9.Xu L, Yu D, Peng L, Fan Y, Chen J, Zheng YT, Wang C, Yao YG.
Characterization of a MAVS ortholog from the Chinese tree shrew (Tupaia belangeri chinensis).
Dev Comp Immunol. 2015 Sep;52(1):58-68.
10.Wang L, Li X, Song YM, Wang B, Zhang FR, Yang R, Wang HQ, Zhang GJ.
Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
Mol Med Rep. 2015 Jul;12(1):609-14.
11.Wang Y, Wei H, Wang X, Du L, Zhang A, Zhou H.
Cellular activation, expression analysis and functional characterization of grass carp IκBα: evidence for its involvement in fish NF-κB signaling pathway.
Fish Shellfish Immunol. 2015 Feb;42(2):408-12.
12.Junmin S, Hongxiang L, Zhen L, Chao Y, Chaojie W.
Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity.
J Tradit Chin Med. 2015 Aug;35(4):440-4.
13.Wei W, Zhang WY, Bai JB, Zhang HX, Zhao YY, Li XY, Zhao SH.
The NF-ҡB modulated miR-195/497 inhibit myoblast proliferation by targeting Igf1r/Insr and cyclin genes.
J Cell Sci. 2016 Jan 1;129(1):39-50.
14.Jin M, Sun CY, Zang BX.
Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Chin J Integr Med. 2016 Jan;22(1):36-41.
15.Zhu Z, Zhao Y, Li J, Tao L, Shi P, Wei Z, Sheng X, Shen D, Liu Z, Zhou L, Tian C, Fan F, Shen C, Zhu P, Wang A, Chen W, Zhao Q, Lu Y.
Cryptotanshinone, a novel tumor angiogenesis inhibitor, destabilizes tumor necrosis factor-α mRNA via decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR.
Mol Carcinog. 2016 Otc;55(10):1399-1410.
16.Xu X, Zhang X, Liu Y, Yang L, Huang S, Lu L, Wang S, Guo Q, Zhao L.
BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversalby Wogonin.
Oncotarget. 2016 Apr 26;7(17):24436-54.
17.Wu X, Liu P, Zhang H, Li Y, Salmani JM, Wang F, Yang K, Fu R, Chen Z, Chen B.
Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway.
BMC Cancer.  2017 Feb 21;17(1):147.
18.Liu Y, Fang X, Zhang X, Huang J, He J, Peng L, Ye C, Wang Y, Xue F, Ai D, Li D, Zhu Y.
Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis.
Br J Pharmacol. 2018 Apr;175(8):1190-1204.